Abstract: We assessed the attitudes of Wyoming physicians, pharmacists, nurses, and nurse practitioners about granting prescriptive authority to nurse practitioners. Support for the issue was mixed, with physicians expressing the strongest disagreement. All groups supported limitation of authority to a specific drug formulary, collaborative regulation, and mandatory certification and continuing education if prescriptive authority is granted to nurse
Introduction
Presently 14 states grant limited prescriptive authority to nurse practitioners (NPs) on an experimental or permanent basis.' 2 Several studies have demonstrated the restrictions that lack of prescriptive authority place on nonphysician primary care providers especially in rural areas. [3] [4] [5] Nevertheless, there is considerable controversy within and among the professions of nursing, pharmacy, and medicine concerning this issue. The purpose of this study was to explore the professional attitudes of pharmacists, physicians, and selected nursing groups regarding the issue in the state of Wyoming, which grants no prescriptive authority to nurse practitioners. In response to a structured question regarding type of physician collaboration, the predominant response in all four groups was that physician-approved protocols should be on file with the regulating body(ies). The majority of all groups also supported mandatory continuing pharmacological education and certification by examination for nurse practitioners with prescriptive authority.
Methodology
In response to an open-ended question concerning the potential benefits of granting nurse practitioners prescriptive authority, all groups mentioned improved services to rural areas, increased accessability and availability of health care, decreased physician loads, improved services to physician shortage and underserved areas, better or more comprehen- One way analysis of variance indicated a significant difference (a = .05) between occupational groups. Scheffe post hoc comparison revealed a significant difference (p < .05) between the nursing groups and the physicians and pharmacists. The physician and pharmacist groups did not differ significantly from each other. Similarly, the two nursing groups did not differ from each other. In response to a similar open-ended question addressing the potential problems associated with nurse practitioners having prescriptive authority, the focus was on professional power struggles, nurse practitioners overstepping their authority/limits, legal/liability uncertainties or problems, inappropriate drug use, and inadequate preparation/education of nurse practitioners, particularly in pharmacology.
Discussion
Based on the findings from this limited, nonrandom sample, there appears to be mixed support for the concept of nurse practitioner prescribing on a limited basis. The limitations of this study in terms of sampling design, low response rate, and geographic locale, however, restrict the generalizability of the findings to other populations.
The following general recommendations may be suggested in relation to nurse practitioner prescribing: * Physician-approved protocols to be on file with regulating agencies; * Prescriptive rights limited to a drug formulary consisting of over-the-counter products, immunizations, oral contraceptives and contraceptive devices, antihistamines/decongestants, non-scheduled analgesics, and selected antibiotics and Schedule V drugs; * Mandatory certification by examination; * Mandatory continuing education in pharmacy and pharmacology; * Collaborative control and regulation through the State Boards of Pharmacy, Medicine, and Nursing. Further research is necessary in the areas of consumer acceptance, cost effectiveness, safety, and feasibility of nurse practitioner prescribing.
